BioCentury
ARTICLE | Clinical News

Avandia rosiglitazone regulatory update

January 28, 2008 8:00 AM UTC

EMEA's CHMP recommended that a contraindication be added to the label for rosiglitazone-containing Type II diabetes drugs stating that the thiazolidinedione (TZD) PPAR gamma agonist must not be used ...